An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...
Population studies and mechanistic research have identified pulmonary tuberculosis as an independent risk factor for lung cancer. Residual scarring and chronic inflammation arising from healed ...
Even after completing treatment for tuberculosis (TB), some patients may remain vulnerable to further lung infections. Scientists at A*STAR Infectious Diseases Labs (A*STAR IDL) have recently ...
Tuberculosis often leaves survivors with lasting structural and functional lung damage despite microbiological cure. Common sequelae include airflow obstruction, restrictive defects, bronchiectasis ...
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...
Our lungs are amazing, quietly doing their thing to keep us breathing and alive. But when they are compromised by disease, the effects can be devastating. Two of the diseases that can have a serious ...
In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased apoptosis (shown in red) in several lung cell populations including ...
SINGAPORE – Even after completing treatment for tuberculosis (TB), some patients may remain vulnerable to further lung infections. Scientists at A*STAR Infectious Diseases Labs (A*STAR IDL) have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results